Hepatitis C and human immunodeficiency virus infection

被引:121
作者
Thomas, DL [1 ]
机构
[1] Johns Hopkins Sch Med, Div Infect Dis, Viral Hepatitis Sect, Baltimore, MD USA
关键词
D O I
10.1053/jhep.2002.36380
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the United States, an estimated 200,000 persons are infected with both hepatitis C virus (HCV) and human immunodeficiency virus (HIV). As the lives of HIV-infected persons have been prolonged by use of highly active antiretroviral therapy, liver disease has emerged as an important, and in some settings, the leading cause of morbidity and mortality. Human immunodeficiency virus infection appears to adversely affect all stages of hepatitis C infection, leading to increased viral persistence and accelerated progression of HCV-related liver disease. In turn, hepatitis C may affect the management of HIV infection, increasing the incidence of liver toxicity caused by antiretroviral medications. The medical management of hepatitis C in HIV-infected persons remains controversial, in part because of the complexity of both infections and potential drug interactions, but chiefly because there is so little published information. Nonetheless, the burden of liver disease is too high to delay management of HIV/HCV-coinfected persons while awaiting better data. instead, the management of hepatitis C today must be based on data generated on persons without HIV and an understanding of both infections. Properly designed studies of therapy in HIV/HCV-coinfected persons are needed to help guide management of these patients in the future.
引用
收藏
页码:S201 / S209
页数:9
相关论文
共 95 条
[21]   Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C [J].
Darby, SC ;
Ewart, DW ;
Giangrande, PLF ;
Spooner, RJD ;
Rizza, CR ;
Dusheiko, GM ;
Lee, CA ;
Ludlam, CA ;
Preston, FE .
LANCET, 1997, 350 (9089) :1425-1431
[22]   Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection [J].
den Brinker, M ;
Wit, FWNM ;
Wertheim-van Dillen, PME ;
Jurriaans, S ;
Weel, J ;
van Leeuwen, R ;
Pakker, NG ;
Reiss, P ;
Danner, SA ;
Weverling, GJ ;
Lange, JMA .
AIDS, 2000, 14 (18) :2895-2902
[23]   ANTIBODY TO HEPATITIS-C VIRUS AMONG CARDIAC-SURGERY PATIENTS, HOMOSEXUAL MEN, AND INTRAVENOUS-DRUG-USERS IN BALTIMORE, MARYLAND [J].
DONAHUE, JG ;
NELSON, KE ;
MUNOZ, A ;
VLAHOV, D ;
RENNIE, LL ;
TAYLOR, EL ;
SAAH, AJ ;
COHN, S ;
ODAKA, NJ ;
FARZADEGAN, H .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1991, 134 (10) :1206-1211
[24]   HETEROSEXUAL COTRANSMISSION OF HEPATITIS-C VIRUS (HCV) AND HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) [J].
EYSTER, ME ;
ALTER, HJ ;
ALEDORT, LM ;
QUAN, S ;
HATZAKIS, A ;
GOEDERT, JJ .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :764-768
[25]  
EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602
[26]  
EYSTER ME, 1994, BLOOD, V84, P1020
[27]   A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon [J].
Fattovich, G ;
Giustina, G ;
Favarato, S ;
Ruol, A ;
Macarri, G ;
Orlandi, F ;
Iaquinto, G ;
Ambrosone, L ;
Francavilla, A ;
Pastore, G ;
Santantonio, MT ;
Romagno, D ;
Bolondi, L ;
Sofia, S ;
Marchesini, A ;
Pisi, E ;
Mazzella, G ;
Roda, E ;
Attaro, L ;
Chiodo, F ;
Mori, F ;
Verucchi, G ;
Lanzini, A ;
Salmi, A ;
Calvi, B ;
Bozzetti, F ;
Radaeli, E ;
Bernasconi, M ;
Pilleri, G ;
Bacca, D ;
Romano, G ;
Mastrapasqua, G ;
Cozzolongo, R ;
Cacopardo, B ;
Nunnari, A ;
Blasi, A ;
Sala, LO ;
Minoli, G ;
Sangiovanni, A ;
Spinzi, GC ;
Colombo, A ;
Camassa, M ;
Riva, D ;
Maggi, G ;
Boccia, S ;
Gualandi, G ;
Nucci, A ;
Pacini, F ;
Marino, N ;
Mazzotta, F .
JOURNAL OF HEPATOLOGY, 1996, 24 (01) :38-47
[28]   Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission [J].
Gibb, DM ;
Goodall, RL ;
Dunn, DT ;
Healy, M ;
Neave, P ;
Cafferkey, M ;
Butler, K .
LANCET, 2000, 356 (9233) :904-907
[29]   Solid organ transplantation in patients with HIV infection [J].
Gow, PJ ;
Pillay, D ;
Mutimer, D .
TRANSPLANTATION, 2001, 72 (02) :177-181
[30]   Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis [J].
Graham, CS ;
Baden, LR ;
Yu, E ;
Mrus, JM ;
Carnie, J ;
Heeren, T ;
Koziel, MJ .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :562-569